DNA Aneuploid Cells Showing Discrepancy of Expression Between c-myc Oncogene Products and GFAP in Malignant Glioma
There are various reports on brain tumors in the rapidly developing research on oncogenes which have been noted to be associated with human malignant tumors. We have made an analytical study of the cell growth of brain tumors using flow cytometry (FCM), and further evaluated our results by applying simultaneous double staining using anti c-myc or GFAP monoclonal antibodies (MoAb). In the present study we described an interesting finding in the relationship between c-myc oncogene products and DNA content in malignant glioma cells obtained at surgery.
KeywordsGlioma Cell Double Staining Glioma Cell Line Malignant Glioma Cell Aneuploid Cell
Unable to display preview. Download preview PDF.
- 1.Sakai N, Kawamoto K, Numa Y, Shoda Y, Matsumura H (1989) Comparison of DNA aneuploidy and histological malignancy in brain tumors. Flow Cytometry 9: 37–42Google Scholar
- 2.Kawamoto K, Inagaki T, Sakai N, Ohuchi M, Yasuda T, Suwa J, Seto Y, Matsu-mura H (1988) Correlation of the cell cycle of glioma with GFAP staining on flow cytometry, using PI-FITC-labelled GFAP double staining technique. Flow Cytometry 8: 48–53Google Scholar
- 3.Sakai N, Kawamoto K, Matsumura H (1989) Flowcytometric analysis on the expression of c-myc products in cultured brain tumors. Neuroimmunol Res 2: 183–187Google Scholar
- 4.Kawamoto K, Sakai N, Imahori T, Matsumura H (1990) Proposal for new classification of DNA-ploidy by flow cytometry. Flow Cytometry 10: 124–131Google Scholar
- 12.Suzuki C, Nagashima C, Noritake S, Takahama M (1986) Oncobiology of the human brain tumor cells with special reference to the two-color immunofluorescence analysis of Vimentin/GFAP and BUdR labelling with use of flow cytometry. Brain Tumor Pathol 4: 69–76Google Scholar